REF-1689 · Bai & Xu, 2026 · Journal of the International Society of Sports Nutrition, · Paper · PubMed

Creatine on its own improved sprint, jump, repeated-sprint and upper-body endurance results against placebo, while β-alanine gave non-significant or task-dependent effects and adding β-alanine to creatine gave no extra benefit, in a network meta-analysis of 52 randomised trials in healthy adult athletes (supplements taken 2 weeks or more; trials PEDro 6 or higher); agility and lower-body muscular endurance did not change, and the abstract reports no aerobic or endurance-event outcome

Main caveat: Risk of bias and certainty of the network estimates are not in the abstract; PEDro 6 or higher is only a threshold for entry.
moderate evidenceMeasured on trained to highly trained athletesRead from the abstract only

Bai and Xu asked whether taking creatine and β-alanine together does more than either alone, since the two act by different routes: creatine speeds phosphocreatine resynthesis and β-alanine raises muscle carnosine, which buffers acid.

They searched three databases to August 2025 for randomised trials of at least 2 weeks of creatine, β-alanine or both in healthy adult athletes and kept 52 trials scoring 6 or more on the PEDro scale.

In a random-effects network, creatine beat placebo for sprint (SMD −0.64; p = 0.04), jump (0.33; p = 0.002), repeated-sprint ability (−0.78; p = 0.01) and upper-body muscular endurance (0.43; p = 0.01), with P-scores of 0.90 or higher in these outcomes. β-Alanine produced non-significant or context-specific effects, the combination showed no synergy, and no supplement changed agility or lower-body muscular endurance.

Heterogeneity ran from 0 to 73% (I²), with no global inconsistency in the network and no substantive publication bias by the authors' account. The authors conclude that creatine alone gives the most consistent gains in high-intensity work and that adding β-alanine adds nothing.

Participants

52 randomised controlled trials of healthy adult athletes.
Number of participants, sex split, age, sports and training level: not in the abstract.

Protocol

Search: PubMed, Scopus and Web of Science to August 2025, PRISMA.
Inclusion: randomised controlled trials; creatine, β-alanine or both, taken for 2 weeks or more; healthy adult athletes; PEDro score of 6 or more.
Outcomes: sprint, jump, agility, upper- and lower-body muscular endurance, repeated-sprint ability.
Analysis: random-effects network meta-analysis; standardised mean differences with 95% CI; P-scores for ranking; I²; global inconsistency; publication bias.
Not in the abstract: doses and loading schedules, trial durations beyond the 2-week minimum, how many trials tested the combination, the risk-of-bias or certainty rating of the network, and any aerobic or endurance outcome despite the title.

Key Results

OutcomeCreatine vs placeboβ-alanineCreatine + β-alanine
SprintSMD −0.64, p = 0.04 (improved)non-significant or context-specific (no figures)no synergistic benefit (no figures)
JumpSMD 0.33, p = 0.002as aboveas above
Repeated-sprint abilitySMD −0.78, p = 0.01 (improved)as aboveas above
Upper-body muscular enduranceSMD 0.43, p = 0.01as aboveas above
Agilitynot affected (p > 0.05)not affectednot affected
Lower-body muscular endurancenot affected (p > 0.05)not affectednot affected
Creatine's P-scores were 0.90 or higher in sprint, jump, repeated-sprint and upper-body endurance outcomes.
The negative SMDs for sprint and repeated sprints are reported as improvements, so they read as shorter times; confidence intervals are not in the abstract.
Heterogeneity I² 0-73%; no global inconsistency; no substantive publication bias (the authors' wording).

Practical Application

For sprint, jump and repeated-sprint goals, creatine alone is the supplement to choose; adding β-alanine to it gave no extra benefit across 52 randomised trials in athletes. This agrees with SYNTH-67, which keeps creatine for strength and sprint goals.
β-Alanine was not a general booster here: its effects were non-significant or depended on the task; the abstract gives no figures. SYNTH-67 already limits it to efforts of about 0.5-10 min, an effort type this abstract's outcome list does not cover, so the paper neither confirms nor contradicts that use.
Nothing here for endurance racing. Despite "aerobic" in the title, no endurance outcome appears in the abstract; caffeine, bicarbonate or β-alanine choices for time trials and races stay with SYNTH-67.
Inference, not tested here: a strength or sprint athlete already on creatine gains little from paying for a creatine-plus-β-alanine stack, and stacking one supplement at a time keeps the response readable (the base's practice in SYNTH-67).
Not settled by this design / not from this paper: doses, how long the combination was taken, effects in women, and how sure the network estimates are (no risk-of-bias or certainty result in the abstract).

Limitations

Risk of bias and certainty of the network estimates are not in the abstract; PEDro 6 or higher is only a threshold for entry.
No confidence intervals, participant numbers or β-alanine and combination estimates in the abstract; "context-specific" is not defined there.
Heterogeneity reached 73% in some outcomes.
Network estimates combine direct and indirect comparisons; how many trials tested the combination directly is not stated.
No endurance outcome despite the title; doses, durations and populations not described.
Written from the abstract and the PubMed record; full text not read.
How this entry was checked and changed
Why this level

risk of bias not read (abstract only): the abstract gives PEDro 6 or higher only as an inclusion threshold and reports no risk-of-bias or certainty result for the network estimates; confidence intervals, participant numbers and every β-alanine and combination estimate are also missing from the abstract